BioPharma raises $163.8m in capital raising
BioPharma Credit, a closed end investment fund that provides debt capital for the life sciences industry, raised $163.8m in a primary share placement on Thursday to fund further investment.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: